BOR - Papers in Press, published online ahead of print
April 30, 2003.
Biol Reprod 2003, 10.1095/biolreprod.102.009290
BIOLOGY OF REPRODUCTION 69, 627633 (2003)
DOI: 10.1095/biolreprod.102.009290
© 2003 by the Society for the Study of Reproduction, Inc.
Human Choriocarcinoma Cell Resistance to Natural Killer Lysis Due to Defective Triggering of Natural Killer Cells1
Tony Avril3,
Sophie Iochmann3,
Denys Brand4,
Pierre Bardos3,
Hervé Watier3, and
Gilles Thibault2,3
EA 3249 «Cellules hématopoïétiques, hémostase et greffe»3
EA 3250 «Microbiologie médicale et moléculaire»,4 Faculté de Médecine, Tours, France
The trophoblast, the outermost layer of the human placenta, lacks expression of the classical human leukocyte antigen (HLA) class I molecules. This prevents allorecognition by T cells but raises the question of what protects the trophoblast from natural killer (NK) cells. In a previous study, we have shown that choriocarcinoma cell (CC) resistance to NK lysis was mainly independent of HLA class I molecules. In the present study, we postulated that CC may prevent activation of NK cells by failing to stimulate their triggering receptors (TR). To test this hypothesis, we evaluated the lysis of JAR and JEG-3 CC after effective cross-linking and activation of NK cells by means of lectins or antibodies. Our results show that NK-resistant CC were sensitive to lysis by unstimulated peripheral blood lymphocytes in the presence of phytohemagglutin (PHA), to antibody-dependent cell cytotoxicity in presence of anti-Tja antibodies, and to monoclonal antibody redirected killing using anti-TR antibodies anti-CD16 and anti-CD244/2B4. Finally, CC fail to express CD48, the ligand for CD244/2B4. These results indicate that the resistance of CC to lysis results primarily from defective NK cell activation, at least partially due to the lack of expression of ligands, such as CD48, involved in the triggering of NK cells.
1 This work was supported by Fondation Langlois. T.A. was supported by a grant from the French Society of Transplantation.
2 Correspondence: G. Thibault, EA 3249 «Cellules hématopoïétiques, hémostase et greffe», Laboratoire d'Immunologie, Faculté de Médecine, 2 bis boulevard Tonnellé, 37032 Tours Cedex, France. FAX: 33 2 4736 6095; thibault{at}med.univ-tours.fr
Copyright © 2003 by the Society for the Study of Reproduction.